Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)

Clinical trial NCT00001959 · COMPLETED

Trial details

NCT number: NCT00001959
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fibrosis Focal Glomerulosclerosis Kidney Failure Nephrotic Syndrome Proteinuria

Start date: 1999-12-01
Primary completion: 2008-10-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.